Treatment for Acute Diastolic Hypotension with Central Shunt Physiology and Moderate TR

Pathophysiology Understanding

Diastolic hypotension with central shunt physiology and moderate tricuspid regurgitation (TR) represents a complex hemodynamic scenario involving right ventricular (RV) dysfunction, abnormal pressure gradients between chambers, and potentially compromised cardiac output, as noted by the European Society of Cardiology 1
Moderate TR can reflect volume overload, pressure overload from pulmonary hypertension, or primary valvular issues, all of which can contribute to diastolic hypotension, according to the European Heart Journal 2

Careful assessment of volume status is critical as both hypovolemia and hypervolemia can worsen the condition, as stated by the European Society of Cardiology and the European Heart Journal 1, 2
If hypervolemic, diuretic therapy may be indicated to optimize volume status, as recommended by the European Heart Journal 3

Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) is the first-line treatment for isolated primary and secondary TR, as stated by the European Heart Journal 3
Loop diuretics are recommended to relieve congestion in patients with right-sided heart failure, according to the European Heart Journal 3
Aldosterone antagonists may be beneficial in managing TR-related volume overload, as noted by the European Heart Journal 3
Rhythm control strategies should be considered in patients with TR and atrial fibrillation, as recommended by the European Heart Journal 3

In patients with moderate TR and tricuspid annular dilation (>40 mm or >21 mm/m²), surgical repair may be considered if the patient is undergoing other cardiac surgery, as stated by the European Heart Journal 2, 4
TV repair with a prosthetic ring is the first-line surgical approach when intervention is indicated, according to the European Heart Journal 3
Surgery is generally not recommended for isolated functional TR in the acute setting, as noted by the European Heart Journal 5
For patients with severe TR and RV dysfunction who are not surgical candidates, transcatheter treatment may be considered at specialized heart valve centers, as recommended by the European Heart Journal 3

The presence of a central shunt requires careful assessment of pulmonary vascular resistance and shunt direction, as stated by the American College of Cardiology 6
TIPS (transjugular intrahepatic portosystemic shunt) creation should be avoided in patients with moderate to severe TR as it can be prohibitive due to the risk of worsening right heart failure, as noted by the European Society of Gastroenterology 1
Careful monitoring of right atrial pressure is essential, as elevated right atrial pressure (>14.5 mmHg) is associated with increased mortality in patients with shunt physiology, according to the European Society of Cardiology 1

Serial echocardiographic assessment to evaluate TR severity, RV function, and shunt physiology, as recommended by the European Heart Journal 2
Surveillance in high-risk patients (e.g., prior heart failure, elevated right atrial pressure, left ventricular dysfunction) may guide pre-emptive interventions, as stated by the European Society of Cardiology 1